Table 1.
PCOS (n = 73) | Control (n = 33) | p | |
---|---|---|---|
Age (years) | 26,9 ± 5,5 | 30,9 ± 5,1 | 0,001 |
BMI (kg/m2) | 31,0 (18,6–46,9) | 22,4 (18,1–37,4) | <0,0001 |
WC (cm) | 102 (69–133) | 81 (52–110) | <0,0001 |
TT (nmol/L) | 2,88 ± 1,18 | 1,70 ± 0,42 | <0,0001 |
bioT (nmol/L) | 1,14 (0,35–2,84) | 0,49 (0,28–0,87) | <0,0001 |
A4 (nmol/L) | 11,5 ± 4,5 | 8,0 ± 4,5 | <0,0001 |
SHBG (nmol/L) | 26,6 (8,2–105) | 61 (19,4–121) | <0,0001 |
Insulin (µUI/ml) | 12,7 (4,2–65,2) | 6,8 (2,2–14,4) | <0,0001 |
HOMA | 3,46 (0,89–17,86) | 1,51 (0,47–3,48) | <0,0001 |
hs-CRP (mg/L) | 2,38 (0,36–14,53) | 1.11 (0,27–9,30) | 0,005 |
LAP (cm.mmol/L) | 53,5 (5,0–203,8) | 17,4 (6,8–93,4) | <0.0001 |
25-OH-D (nmol/L) | 28,8 (25–64) | 42,8 (62,5–97) | 0,020 |
Cortisol (nmol/L) | 342,1 ± 129,7 | 369,7 ± 102,1 | ns |
Results are expressed as median (range) or mean ± SD according to distribution. BMI: body mass index, WC: waist circumference, TT: total testosterone, bioT: bioavailable testosterone, A4: androstenedione, hs-CRP: high sensitive C reactive protein, LAP: lipid accumulation product, 25-OH-D: 25-hydroxyvitamin D.